However, the lack of association between IGF-I, IGF-II, or IGFBP-3 and pancreatic cancer in cases and matched controls with eight or more years between plasma collection and cancer diagnosis is reassuring that we are not missing a large effect of these plasma markers. The gene discussed is IGF1; the disease is familial pancreatic carcinoma.